Stereotactic body radiation therapy for low- to intermediate-risk prostate cancer has potential cost savings and may improve access to radiation, increase convenience, and boost quality of life.
Joseph C. Hodges, MD, MBA
Advertisement
Articles by Joseph C. Hodges, MD, MBA
Advertisement
Latest Updated Articles
- Cost-Effectiveness Analysis of SBRT Versus IMRT: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer
Published: May 9th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
COVID-19 Vaccination Linked to Lower Risk of Long COVID in Adolescents
2
Breast Cancer Dominating Oncology Research, Access Disparities: Gen Li, PhD
3
Role of MRAs in Heart Failure Treatment
4
Nearly All US Youth With BMI-Defined Obesity Have Excess Adiposity
5
